Kiromic BioPharma
cell therapy strong efficacy cell therapy strong safety | Kiromic BioPharma
Company
Deck Type
Sector
Industry
Deck date
May 2023
Slide
16 of 25
Related slides by other companies
Ocuphire Pharma
Results
October 2022
has the potential to be first line of therapy for patients efficacy signal safety non invasive treatment option guidance physician patients efficacy signal safety non invasive treatment option | Ocuphire Pharma
Karooooo
Results
October 2022
safety in cash flow generation | Karooooo
Mink Therapeutics
Investor Day
November 2022
mink | Mink Therapeutics
Karooooo
Results
July 2022
safety in cash flow generation | Karooooo
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights